Skip to content

Clinical trials

Phase 2 Bacteremia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacteremia Phase: Phase 2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20081
20101
20112
20141
20174
20181
20211
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Unknown status3
Withdrawn2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Anderson Clinical Research1
Basilea Pharmaceutica1
Bristol-Myers Squibb1
ContraFect1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Duke University1
LigaChem Biosciences, Inc.1
M.D. Anderson Cancer Center1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacteremia20
Staphylococcal Infections7
Sepsis4
Endocarditis3
Infections3
AIDS-Related Opportunistic Infections1
Bronchopulmonary Dysplasia1
Chronic Periodontitis1
Communicable Diseases1
Endocarditis, Bacterial1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.